SCRICON 2024 marks a new era in Cancer Research and Treatment, hosted by Shalby Hospitals in Ahmedabad. Conference served as a catalyst for new research, innovative treatments, and collaborative efforts in the fight against cancer.
The event featured keynote presentations, panel discussions, and poster sessions. Dr. Viraj Lavingia, Head of Medical Oncology at Shalby Hospitals, Ahmedabad, stated, “’SCRICON 2024’ is more than a conference; it’s a convergence of minds dedicated to pushing the boundaries of cancer research and treatment. We are thrilled to host some of the brightest minds in oncology and witness ground-breaking discussions that will shape the future of cancer care.”
Attendees engaged with renowned oncologists, researchers, and healthcare professionals, fostering meaningful connections and potential collaborations. Dr. Rakesh Shah, Cluster Chief Operating Officer of Shalby Hospitals, added, “Our aim with ‘SCRICON 2024’ was to create a platform where experts from diverse fields could share knowledge, exchange best practices, and explore the latest advancements in oncology. This collaborative spirit is essential to improving patient outcomes and driving innovation in cancer treatment.”
Dr. Nishita Shukla, Group Chief Operating Officer of Shalby Hospitals, expressed, “The conference is an expression of our commitment to advancing the understanding of cancer and working towards a brighter future for those affected by this disease. Shalby Cancer Research Institute is committed to fighting against this disease through its clinicians and support team across all its hospitals Pan India.”
The Shalby Cancer Research Institute aims to create awareness for prevention and provide state-of-the-art treatments with empathy and compassion for all patients. The institute also focuses on clinical research and academics, ensuring a comprehensive approach to patient care.
‘SCRICON 2024’ has set the stage for ongoing efforts to enhance cancer research and treatment, ensuring a positive impact on patient care and outcomes.
